WO2023108208 - BROMOFORM-PRODUCING TRANSGENIC PLANTS
National phase entry is expected:
Publication Number
WO/2023/108208
Publication Date
22.06.2023
International Application No.
PCT/AU2022/051499
International Filing Date
14.12.2022
Title **
[English]
BROMOFORM-PRODUCING TRANSGENIC PLANTS
[French]
PLANTES TRANSGÉNIQUES PRODUISANT DU BROMOFORME
Applicants **
MICKLE, John
Inventors
MICKLE, John
Priority Data
2021904048
14.12.2021
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2983 | |
| EPO | Filing, Examination, Granting | 19438 | |
| Japan | Filing, Examination, Granting | 3077 | |
| South Korea | Filing, Examination, Granting | 4130 | |
| USA | Filing, Examination, Granting | 10940 |
Total:
40,568
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The technology relates to transgenic plant cells comprising at least one copy of an expression cassette comprising a promoter that causes the production of a mRNA transcript and a nucleic acid sequence encoding a vanadate-dependent bromoperoxidase (vBPO). The plant cell may be part of a plant, which may express the vBPO in only some plant organs or tissues. The transgenic plant or an extract thereof may be used as an animal feed supplement or animal feed. The presence of bromoform in the transgenic plants means that they can reduce the methane emissions of animals that they are fed to.[French]
L'invention concerne des cellules végétales transgéniques comprenant au moins une copie d'une cassette d'expression comprenant un promoteur qui provoque la production d'un transcrit d'ARNm et une séquence d'acide nucléique codant pour une bromoperoxydase dépendante du vanadate (vBPO). La cellule végétale peut faire partie d'une plante, qui peut exprimer la vBPO uniquement dans certains organes ou tissus végétaux. La plante transgénique ou un extrait de celle-ci peut être utilisé comme complément alimentaire pour animaux ou comme aliment pour animaux. La présence de bromoforme dans les plantes transgéniques signifie qu'elles peuvent réduire les émissions de méthane des animaux qu'elles alimentent.